SCHEMBL6775285

SCHEMBL6775285

CC(C)c1ccc(C(=O)N(Cc2ccccc2-c2ccccc2)c2cccnc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ KCNA5 P22460 6/20 0.46
▸ HTT P42858 1/20 0.45
▸ KCNH2 Q12809 3/20 0.44
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2B6 P20813 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ TBXAS1 P24557 1/20 0.39
▸ LTB4R2 Q9NPC1 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ GPBAR1 Q8TDU6 2/20 0.39
▸ LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6779598 0.78 PDK1 (0.54) GAATSHRHTTNPC1RAB9A
SCHEMBL6780403 0.78 TSHR (0.44) GAATSHRKCNA5HTTKCNH2
SCHEMBL6784632 0.76 NR1H4 (0.53) GAATSHRHTTNPC1RAB9A
SCHEMBL6781088 0.76 ALDH1A1 (0.45) GAATSHRKCNA5HTTCYP3A4
SCHEMBL6780637 0.74 LMNA (0.46) GAATSHRKCNA5HTTKCNH2
SCHEMBL6784951 0.74 KMT2A (0.44) GAATSHRHTTNPC1RAB9A
SCHEMBL6780065 0.73 NPY2R (0.42) GAATSHRKCNA5HTTKCNH2
SCHEMBL6784990 0.73 PTGES (0.54) GAATSHRNPC1RAB9AALDH1A1
SCHEMBL4764550 0.73 LTB4R2 (0.47) GAATSHRHTTLTB4R2ALDH1A1
SCHEMBL13571398 0.72 TSHR (0.84) GAATSHRKCNA5HTTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US claimed
US-6780883-B2 ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS; ANTILIPEMIC AGENTS; RESTENOSIS; DIETETICS WARNER-LAMBERT COMPANY 2004-08-24 — — US disclosed
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein CETP, MTTP, LCAT GAA 596/4885TSHR 1297/4885KCNA5 3796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback